comparemela.com

Latest Breaking News On - Software precertification pilot program - Page 5 : comparemela.com

Pear Therapeutics Announces Agreement with SoftBank Corp to Develop a Digital Therapeutic for Sleep/Wake Disorders for the Japanese Market

Pear Therapeutics, Inc. , the leader in developing and commercializing software-based medicines called prescription digital therapeutics , today announced an agreement with SoftBank Corp. to develop. | March 21, 2022

Digital therapeutics face barriers to growth as Pear takes early steps toward sales targets

Pear Therapeutics Announces Operational Performance Metrics for Full Year 2021 and Reaffirms Financial and Operational Performance Metrics for Full Year 2022

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.